Domanion may be available in the countries listed below.
Perindopril erbumine (a derivative of Perindopril) is reported as an ingredient of Domanion in the following countries:
International Drug Name Search
Definition of Diabetes, Type 1: Type 1 diabetes mellitus, more commonly known as type 1 diabetes, is a disease in which the pancreas produces too little insulin to meet the body's needs. Insulin is a hormone that helps control the level of glucose in the blood. Glucose is the main form of sugar in the body.
The following drugs and medications are in some way related to, or used in the treatment of Diabetes, Type 1. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Micromedex Care Notes:
Medical Encyclopedia:
See also: Generic Xanax
Xanax XR is a brand name of alprazolam, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Xanax XR:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xanax XR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Xanax XR.
Talmea may be available in the countries listed below.
Alclometasone 17α,21-dipropionate (a derivative of Alclometasone) is reported as an ingredient of Talmea in the following countries:
International Drug Name Search
Generic Name: black haw (black HA)
Brand Names:
The use of black haw in cultural and traditional settings may differ from concepts accepted by current Western medicine. When considering the use of herbal supplements, consultation with a primary health care professional is advisable. Additionally, consultation with a practitioner trained in the uses of herbal/health supplements may be beneficial, and coordination of treatment among all health care providers involved may be advantageous.
Black haw is also known as blackhaw viburnum, cramp bark, sheepberry, shonny, sloe, sloe-leaved viburnum, stagbush, sweethaw, American sloe, king's crown, sheep berry, snowball, tree stagbush and others.
Black haw has been used to ease the symptoms of menopause and menstrual discomfort. Black haw has also been used for false labor pains and in threatened miscarriage. In addition, it has been used to lower blood pressure in hypertension and as an anti-spasmodic the treatment of asthma.
Black haw has not been evaluated by the FDA for safety, effectiveness, or purity. All potential risks and/or advantages of black haw may not be known. Additionally, there are no regulated manufacturing standards in place for these compounds. There have been instances where herbal/health supplements have been sold which were contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.
Black haw may also have uses other than those listed in this product guide.
Black haw has not been evaluated by the FDA for safety, effectiveness, or purity. All potential risks and/or advantages of black haw may not be known. Additionally, there are no regulated manufacturing standards in place for these compounds. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.
Before taking black haw, talk to your doctor, pharmacist, or health care professional if you have allergies (especially to plants), have any medical condition, or if you take other medicines or other herbal/health supplements. Black haw may not be recommended in some situations.
The use of black haw in cultural and traditional settings may differ from concepts accepted by current western medicine. When considering the use of herbal supplements, consultation with a primary health care professional is advisable. Additionally, consultation with a practitioner trained in the uses of herbal/health supplements may be beneficial, and coordination of treatment among all health care providers involved may be advantageous.
If you choose to take black haw, use it as directed on the package or as directed by your doctor, pharmacist, or other health care provider.
Standardized extracts, tinctures, and solid formulations of herbal/health supplements may provide a more reliable dose of the product.
To ensure the correct dose, measure the liquid forms of black haw with a dropper or a dose-measuring spoon or cup.
Some forms of black haw can be brewed to form a tea for drinking.
Store black haw as directed on the package. In general, black haw should be protected from light and moisture.
Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra black haw to make up the missed dose.
Symptoms of a black haw overdose are not well known but might include nausea, dizziness, seizures, visual disturbances, reduced pulse rate, and increased perspiration.
Follow your healthcare provider's instructions about any restrictions on food, beverages, or activity.
Large doses of black haw have been reported to cause
nausea,
dizziness,
seizures,
visual disturbances,
reduced pulse rate, and
increased sweating.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Interactions between black haw and other prescription or over-the-counter medicines or herbal/health supplements have not been reported. Talk to your doctor, pharmacist, or health care professional before taking black haw if you are taking any other medicines or supplements.
Fluoxetina Bluepharma may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Bluepharma in the following countries:
International Drug Name Search
EryPed is a brand name of erythromycin, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of EryPed available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of EryPed. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with EryPed.
Oxybutynin Winthrop may be available in the countries listed below.
Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin Winthrop in the following countries:
International Drug Name Search
Lansoprazolo Mylan may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Lansoprazolo Mylan in the following countries:
International Drug Name Search
(potency expressed as betamethasone)
*Vehicle augments the penetration of the steroid
For Dermatologic Use Only - Not for Ophthalmic Use
Rx only
Betamethasone Dipropionate Gel (Augmented), 0.05%, contains betamethasone dipropionate, USP, a synthetic fluorinated corticosteroid for topical dermatologic use. Betamethasone dipropionate is included in a class of compounds consisting primarily of synthetic corticosteroids for use topically as anti-inflammatory and antipruritic agents.
Chemically, betamethasone dipropionate is 9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, with the empirical formula C28H37FO7, a molecular weight of 504.6 and the following structural formula:
Betamethasone dipropionate is a white to creamy white, odorless crystalline powder, insoluble in water.
Each gram of Betamethasone Dipropionate Gel (Augmented) contains: 0.643 mg betamethasone dipropionate, USP (equivalent to 0.5 mg betamethasone) in an augmented gel base of carbomer 940, NF; propylene glycol, USP; purified water, USP; and sodium hydroxide NF.
Like other topical corticosteroids, betamethasone dipropionate has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, topical corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes, by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.
The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle and the integrity of the epidermal barrier. Occlusive dressings with hydrocortisone for up to 24 hours have not been demonstrated to increase penetration; however, occlusion of hydrocortisone for 96 hours markedly enhances penetration. Topical corticosteroids can be absorbed from normal intact skin. In addition, inflammation and/or other disease processes in the skin may increase percutaneous absorption. Studies performed with Betamethasone Dipropionate Gel (Augmented) indicate that it is in the super-high range of potency as compared with other topical corticosteroids.
Betamethasone Dipropionate Gel (Augmented) is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond two consecutive weeks is not recommended, and the total dose should not exceed 50 g per week because of potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Betamethasone Dipropionate Gel (Augmented) is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Betamethasone Dipropionate Gel (Augmented) should not be used in the treatment of rosacea or perioral dermatitis, and it should not be used on the face, groin, or in the axillae.
Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Manifestations of Cushing's syndrome, hyperglycemia, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment.
At 7 g per day (applied once daily or as 3.5 g twice daily), Betamethasone Dipropionate Gel (Augmented) was shown to cause inhibition of the HPA axis following application for 1, 2 or 3 weeks to diseased skin in some patients with psoriasis or atopic dermatitis. These effects were reversible upon discontinuation of treatment.
Patients receiving Betamethasone Dipropionate Gel (Augmented) applied to large areas should be evaluated periodically for evidence of HPA axis suppression. This may be done by using the ACTH-stimulation, morning plasma cortisol and urinary free cortisol tests. Patients should not be treated with Betamethasone Dipropionate Gel (Augmented) for more than 2 weeks at a time, and amounts greater than 50 g per week should not be used because of the potential for the drug to suppress the HPA axis.
If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid. Recovery of HPA axis function is generally prompt and complete upon discontinuation of topical corticosteroids. Infrequently, signs and symptoms of glucocorticosteroid insufficiency may occur, requiring supplemental systemic corticosteroids. For information on systemic supplementation, see prescribing information for systemic corticosteroids.
Pediatric patients may be more susceptible to systemic toxicity from equivalent doses due to their larger skin surface to body mass ratios (see PRECAUTIONS - Pediatric Use).
If irritation develops, Betamethasone Dipropionate Gel (Augmented) should be discontinued and appropriate therapy instituted. Allergic contact dermatitis with corticosteroids is usually diagnosed by observing failure to heal rather than noting clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing.
If concomitant fungal and/or bacterial skin infections are present or develop, an appropriate anti-fungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of Betamethasone Dipropionate Gel (Augmented) should be discontinued until the infection has been adequately controlled.
Patients using topical corticosteroids should receive the following information and instructions:
The following tests may be helpful in evaluating patients for HPA axis suppression:
Long term animal studies have not been performed to evaluate the carcinogenic potential of betamethasone dipropionate.
Studies in rabbits, mice and rats using intramuscular doses up to 1.0, 33 and 2.0 mg/kg, respectively, resulted in dose-related increases in fetal resorptions in the rabbits and mice.
Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals.
Betamethasone dipropionate has been shown to be teratogenic in rabbits when given by the intramuscular route at doses of 0.05 mg/kg. This dose is approximately 26 times the human topical dose of Betamethasone Dipropionate Gel (Augmented) assuming human percutaneous absorption of approximately 3% and the use in a 70-kg person of 7 g per day. The abnormalities observed included umbilical hernias, cephalocele, and cleft palate.
There are no adequate and well-controlled studies of the teratogenic potential of betamethasone dipropionate in pregnant women. Therefore, Betamethasone Dipropionate Gel (Augmented) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when Betamethasone Dipropionate Gel (Augmented) is administered to a nursing woman.
Data regarding use of Betamethasone Dipropionate Gel (Augmented) in pediatric patients are not available, so use of this product in patients under the age of 12 is not recommended. Because of a higher ratio of skin surface area to body mass, pediatric patients are at a greater risk than adults of HPA axis suppression when they are treated with topical corticosteroids. They are, therefore, also at greater risk of glucocorticosteroid insufficiency after withdrawal of treatment and of Cushing's syndrome while on treatment. Adverse effects, including striae, have been reported with inappropriate use of topical corticosteroids in infants and children.
HPA axis suppression, Cushing's syndrome, and intracranial hypertension have been reported in pediatric patients receiving topical corticosteroids. Manifestations of adrenal suppression in pediatric patients include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema.
Clinical studies of Betamethasone Dipropionate Gel (Augmented) included 65 subjects who were 65 years of age and over and 15 subjects who were 75 years of age and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients. However, greater sensitivity of some older individuals cannot be ruled out.
In controlled clinical trials, the total incidence of adverse events associated with the use of Betamethasone Dipropionate Gel (Augmented) was 10%. These included stinging or burning in 6% of patients, dry skin in 4% of patients, and pruritus in 2% of patients. Less frequently reported adverse reactions were irritation, skin atrophy, telangiectasia, erythema, cracking/tightening of the skin, follicular rash, and allergic contact dermatitis.
The following additional local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with super-high potency corticosteroids, such as Betamethasone Dipropionate Gel (Augmented). These reactions are listed in approximate decreasing order of occurrence: acneiform eruptions, hypopigmentation, perioral dermatitis, secondary infection, striae, and miliaria.
Topically applied Betamethasone Dipropionate Gel (Augmented) can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS).
Apply a thin layer of Betamethasone Dipropionate Gel (Augmented) to the affected skin once or twice daily and rub in gently and completely.
Betamethasone Dipropionate Gel (Augmented) is a super-high potency topical corticosteroid; therefore, treatment should be limited to 2 weeks, and amounts greater than 50 g per week should not be used.
Betamethasone Dipropionate Gel (Augmented) should not be used with occlusive dressings.
Betamethasone Dipropionate Gel (Augmented) is supplied in 15 g and 50 g tubes; and 5 g physician sample.
Store at 20° - 25°C (68° - 77°F) [See USP Controlled Room Temperature]
Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1
Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532
Issued: October, 2003
PK-4240-0 158
NDC 51672-1309-1
15 g
Betamethasone Dipropionate
Gel (Augmented*), 0.05%
(Potency expressed as betamethasone)
*Vehicle augments the penetration of the steroid.
FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE.
Rx only
Keep this and all medications out of the reach of children.
TARO
| BETAMETHASONE DIPROPIONATE betamethasone dipropionate gel | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA076508 | 12/02/2003 | |
| Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE | |
Zeldilon may be available in the countries listed below.
Minoxidil is reported as an ingredient of Zeldilon in the following countries:
International Drug Name Search
Pamidronato Teva may be available in the countries listed below.
Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Pamidronato Teva in the following countries:
International Drug Name Search
Nitrosorbide Retard may be available in the countries listed below.
Isosorbide Dinitrate is reported as an ingredient of Nitrosorbide Retard in the following countries:
International Drug Name Search
Protagen may be available in the countries listed below.
Chlormadinone 17α-acetate (a derivative of Chlormadinone) is reported as an ingredient of Protagen in the following countries:
International Drug Name Search
BMD-100 Antibiotic Feed Premix may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of BMD-100 Antibiotic Feed Premix in the following countries:
International Drug Name Search
Kokonalin may be available in the countries listed below.
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Kokonalin in the following countries:
International Drug Name Search
Duranifin may be available in the countries listed below.
Nifedipine is reported as an ingredient of Duranifin in the following countries:
International Drug Name Search
Ketopamin may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Ketopamin in the following countries:
International Drug Name Search
Delco Spray may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Delco Spray in the following countries:
International Drug Name Search
Emselex may be available in the countries listed below.
UK matches:
Darifenacin hydrobromide (a derivative of Darifenacin) is reported as an ingredient of Emselex in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Nitrazepam AccordHealthcare may be available in the countries listed below.
Nitrazepam is reported as an ingredient of Nitrazepam AccordHealthcare in the following countries:
International Drug Name Search
Luricul VG may be available in the countries listed below.
Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Luricul VG in the following countries:
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Luricul VG in the following countries:
International Drug Name Search
Colirio Alfa may be available in the countries listed below.
Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Colirio Alfa in the following countries:
International Drug Name Search
SciLin N may be available in the countries listed below.
Insulin, Isophane human (a derivative of Insulin, Isophane) is reported as an ingredient of SciLin N in the following countries:
International Drug Name Search
Definition of Conjunctivitis: Conjunctivitis is inflammation or infection of the membrane lining the eyelids (conjunctiva).
The following drugs and medications are in some way related to, or used in the treatment of Conjunctivitis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Medical Encyclopedia:
Harvard Health Guide:
Troxérutine Qualimed may be available in the countries listed below.
Troxerutin is reported as an ingredient of Troxérutine Qualimed in the following countries:
International Drug Name Search
Epitrim may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Epitrim in the following countries:
Trimethoprim is reported as an ingredient of Epitrim in the following countries:
International Drug Name Search
Pinavérium Arrow may be available in the countries listed below.
Pinaverium Bromide is reported as an ingredient of Pinavérium Arrow in the following countries:
International Drug Name Search
Amlodipin dura may be available in the countries listed below.
Amlodipine mesilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipin dura in the following countries:
International Drug Name Search
Andolex may be available in the countries listed below.
Benzydamine hydrochloride (a derivative of Benzydamine) is reported as an ingredient of Andolex in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
BAN
P03AC02
0000584-79-2
C19-H26-O3
302
Insecticide
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
Alfa Bergamon may be available in the countries listed below.
Didecyldimethylammonium Chloride is reported as an ingredient of Alfa Bergamon in the following countries:
International Drug Name Search
Critpan may be available in the countries listed below.
Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Critpan in the following countries:
International Drug Name Search
Tindal may be available in the countries listed below.
Permethrin is reported as an ingredient of Tindal in the following countries:
International Drug Name Search
Mépivacaïne may be available in the countries listed below.
Mépivacaïne (DCF) is known as Mepivacaine in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
The following drugs and medications are in some way related to, or used in the treatment of Cryoglobulinemia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Medical Encyclopedia:
In the US, Sufentanil (sufentanil systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia.
US matches:
Rec.INN
N01AH03
0056030-54-7
C22-H30-N2-O2-S
386
Opioid analgesic
Propanamide, N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Tamsulosin HCl Teva may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosin HCl Teva in the following countries:
International Drug Name Search
Corodrox may be available in the countries listed below.
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Corodrox in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Esophageal Candidiasis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Medical Encyclopedia:
Capobal may be available in the countries listed below.
Captopril is reported as an ingredient of Capobal in the following countries:
International Drug Name Search
Kétoconazole Teva may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Kétoconazole Teva in the following countries:
International Drug Name Search
Novalsung may be available in the countries listed below.
Paracetamol is reported as an ingredient of Novalsung in the following countries:
International Drug Name Search
Flixoderm may be available in the countries listed below.
Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Flixoderm in the following countries:
International Drug Name Search
Maxivanil may be available in the countries listed below.
Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Maxivanil in the following countries:
International Drug Name Search
Aldisa SR may be available in the countries listed below.
Loratadine is reported as an ingredient of Aldisa SR in the following countries:
Pseudoephedrine sulfate (a derivative of Pseudoephedrine) is reported as an ingredient of Aldisa SR in the following countries:
International Drug Name Search
Chlorhydrate de Phenylephrine-Chauvin may be available in the countries listed below.
Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Chlorhydrate de Phenylephrine-Chauvin in the following countries:
International Drug Name Search
Biragan Codein may be available in the countries listed below.
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Biragan Codein in the following countries:
Paracetamol is reported as an ingredient of Biragan Codein in the following countries:
International Drug Name Search
In the US, Insulin Aspart (insulin aspart systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1 and Diabetes - Type 2.
US matches:
Rec.INN
A10AB05,A10AD05
0116094-23-6
C256-H381-N65-O79-S6
5826
Antidiabetic agent
Insulin analogue, recombinant human
28B-L-aspartic acid-insulin (human)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
There are currently no drugs listed for "Thrombocytopathy".
Definition of Thrombocytopathy: A disorder of the blood coagulating mechanism that results from dysfunction of the platelets.
Medical Encyclopedia:
Aciclovir Creme-1A Pharma may be available in the countries listed below.
Aciclovir is reported as an ingredient of Aciclovir Creme-1A Pharma in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Ear Conditions. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Definition of Nephrocalcinosis: A kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules and interstitium (the areas between the tubules); this may result in reduced kidney function.
The following drugs and medications are in some way related to, or used in the treatment of Nephrocalcinosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Medical Encyclopedia:
Ranfen may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ranfen in the following countries:
International Drug Name Search
